Akebia Therapeutics Inc. (AKBA)
1.93
0.04 (2.12%)
At close: Jan 15, 2025, 3:47 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -4.48 | -0.99 | -1.53 | -1.11 | -2.68 | -3.76 | -8.41 | -2.89 | -5.63 | -4.84 | -39.07 | -33.01 |
| PS Ratio | 1.19 | 0.36 | 1.76 | 1.31 | 2.23 | 3.11 | 3.63 | 255.79 | n/a | n/a | n/a | n/a |
| PB Ratio | -7.6 | 11.29 | 4.91 | 1.57 | 1.90 | 1.02 | 5.42 | 5.76 | 2.61 | 1.72 | 16.73 | -100.97 |
| P/FCF Ratio | -9.94 | -1.44 | -1.48 | -3.5 | -2.83 | -6.52 | -11.19 | 7.11 | -6.47 | -6.47 | -45.32 | -37.52 |
| P/OCF Ratio | -9.94 | -1.44 | -1.48 | -3.51 | -2.91 | -6.63 | -11.52 | 6.78 | -6.53 | -6.53 | -45.4 | -37.52 |
| OCF/S Ratio | -0.12 | -0.25 | -1.18 | -0.37 | -0.77 | -0.47 | -0.32 | 37.72 | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -3.41 | 10.68 | 1.78 | 0.51 | 0.27 | 0.02 | n/a | 0.00 | 0.00 | n/a | 0.00 | n/a |
| Quick Ratio | 1.03 | 1.31 | 0.91 | 1.66 | 0.93 | 1.33 | 2.48 | 2.59 | 11.88 | 16.05 | 8.57 | 0.46 |
| Current Ratio | 1.18 | 1.48 | 1.06 | 1.98 | 1.49 | 1.76 | 2.48 | 2.59 | 11.88 | 16.05 | 8.57 | 0.46 |
| Asset Turnover | 0.81 | 0.83 | 0.41 | 0.46 | 0.43 | 0.21 | 0.49 | 0.01 | n/a | n/a | n/a | n/a |
| Interest Coverage | -7.67 | -4.03 | -13.31 | -42.44 | -204.49 | -28.95 | n/a | n/a | -120.61 | -184.17 | -22.65 | n/a |
| Return on Equity (ROE) | 1.70 | -11.35 | -3.2 | -1.41 | -0.71 | -0.27 | -0.64 | -1.99 | -0.46 | -0.36 | -0.43 | 3.06 |
| Return on Assets (ROA) | -0.21 | -0.3 | -0.47 | -0.54 | -0.36 | -0.17 | -0.21 | -0.45 | -0.42 | -0.33 | -0.38 | -3.65 |
| Return on Capital (ROIC) | -0.33 | -0.28 | -0.99 | -0.82 | -0.51 | -0.24 | -0.36 | -0.73 | -0.47 | -0.36 | -0.52 | 3.18 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 61.90% | 71.02% | 28.18% | -0.2% | 56.62% | 96.30% | 99.65% | -7.44K% | n/a | n/a | n/a | n/a |
| Net Profit Margin | -26.68% | -36.23% | -114.65% | -118.48% | -83.48% | -82.75% | -43.21% | -8.84K% | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -26.68% | -31.63% | -132.43% | -129.85% | -85.46% | -82.75% | -43.21% | -8.84K% | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -23.77% | -21.59% | -124.23% | -127.47% | -85.46% | -85.75% | -44.9% | -8.89K% | n/a | n/a | n/a | n/a |
| FCF Margin | -12.02% | -25.04% | -118.47% | -37.49% | -78.83% | -47.7% | -32.46% | 3.60K% | n/a | n/a | n/a | n/a |
| EBITDA Margin | -3.53% | -14.78% | -105.8% | -115.47% | -73.92% | -85.73% | -42.73% | -8.87K% | n/a | n/a | n/a | n/a |